These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 594319)

  • 21. The effect of variation within inhibitory domains on the activity of pea protease inhibitors from the Bowman-Birk class.
    Clemente A; MacKenzie DA; Jeenes DJ; Domoney C
    Protein Expr Purif; 2004 Jul; 36(1):106-14. PubMed ID: 15177291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory properties of nonapeptide loop structures related to reactive sites of soybean Bowman-Birk inhibitor.
    Terada S; Sato K; Kato T; Izumiya N
    FEBS Lett; 1978 Jun; 90(1):89-92. PubMed ID: 658446
    [No Abstract]   [Full Text] [Related]  

  • 23. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation, crystallization, and preliminary crystallographic data of the ternary complex of alpha-chymotrypsin, beta-trypsin, and the Bowman-Birk inhibitor.
    Gaier JR; Tulinsky A; Liener IE
    J Biol Chem; 1981 Nov; 256(22):11417-9. PubMed ID: 7298611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and properties of complexes of the Bowman-Birk soybean inhibitor with trypsin and chymotrypsin.
    Seidl DS; Liener IE
    J Biol Chem; 1972 Jun; 247(11):3533-8. PubMed ID: 5063985
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
    Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
    Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP; Zamolodchikova TS; Sokolova EA; Larionova NI
    Biochemistry (Mosc); 1999 Nov; 64(11):1244-9. PubMed ID: 10611528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical substitutions of the reactive site leucine residue in soybean Bowman-Birk proteinase inhibitor with other amino acids.
    Odani S; Ono T
    J Biochem; 1980 Nov; 88(5):1555-8. PubMed ID: 7462194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scission of soybean Bowman-Birk proteinase inhibitor into two small fragments having either trypsin or chymotrypsin inhibitory activity.
    Odani S; Ikenaka T
    J Biochem; 1973 Oct; 74(4):857-60. PubMed ID: 4797073
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetics of native and modified Bowman-Birk soya-bean trypsin inhibitor on growth and enzymes activities of the chick pancreas.
    Madar Z
    Br J Nutr; 1979 Jul; 42(1):121-6. PubMed ID: 486387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of the secondary structure of Bowman-Birk soybean protease inhibitor from LTS sequence.
    Ventura MM
    An Acad Bras Cienc; 1985 Sep; 57(3):359-67. PubMed ID: 3832979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [X-ray structure analyses of proteinase inhibitors].
    Suzuki A; Yamane T; Ashida T
    Tanpakushitsu Kakusan Koso; 1989 Jul; 34(8):929-38. PubMed ID: 2798908
    [No Abstract]   [Full Text] [Related]  

  • 34. High-performance capillary electrophoresis for the determination of trypsin and chymotrypsin inhibitors and their association with trypsin, chymotrypsin and monoclonal antibodies.
    Arentoft AM; Frøkiaer H; Michaelsen S; Sørensen H; Sørensen S
    J Chromatogr A; 1993 Oct; 652(1):189-98. PubMed ID: 8281254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds.
    Ragg EM; Galbusera V; Scarafoni A; Negri A; Tedeschi G; Consonni A; Sessa F; Duranti M
    FEBS J; 2006 Sep; 273(17):4024-39. PubMed ID: 16889634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on soybean trypsin inhibitors. IV. Change of the inhibitory activity of Bowman-Birk inhibitor upon replacements of the alpha-chymotrypsin reactive site serine residue by other amino acids.
    Odani S; Ikenaka T
    J Biochem; 1978 Jul; 84(1):1-9. PubMed ID: 690093
    [No Abstract]   [Full Text] [Related]  

  • 37. Dimeric crystal structure of a Bowman-Birk protease inhibitor from pea seeds.
    Li de la Sierra I; Quillien L; Flecker P; Gueguen J; Brunie S
    J Mol Biol; 1999 Jan; 285(3):1195-207. PubMed ID: 9887273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
    Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on soybean trypsin inhibitors. IV. Complete amino acid sequence and the anti-proteinase sites of Bowman-Birk soybean proteinase inhibitor.
    Odani S; Ikenaka T
    J Biochem; 1972 May; 71(5):839-48. PubMed ID: 4672481
    [No Abstract]   [Full Text] [Related]  

  • 40. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.